
    
      BIIB037 is an investigational product being developed as a treatment for Alzheimer's disease
      (AD). BIIB037 is a fully human immunoglobulin gamma 1 (IgG1) monoclonal antibody that is
      selective for the fibrillar form of beta amyloid (AÃŸ).
    
  